Trial NCT04158700

View at ClinicalTrials.gov 
Org. Study IDs: 17387
Secondary IDs: 2019-001156-18 I8X-MC-JECD KEYNOTE-961

Last trial update was posted on 2020-02-19

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Cancer

Stopping Reasons

The withdrawal is due to a strategic realignment and is not related to any particular safety or efficacy concern.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID